Dyrager Group
Targeting hypoxia in cancer therapy and diagnosis
Our group works on the design and synthesis of “brilliant” (fluorescent) compounds as molecular probes for cell imaging applications. We are mainly interested in compounds that can accumulate specifically in hypoxic cancer cells and thus be used as diagnostic tools in the field of oncology. Our research is multidisciplinary and includes organic synthesis, photophysics, enzymatic reactions and cell studies.
Group members
Publications
Part of Proceedings of the National Academy of Sciences of the United States of America, 2024
Part of Journal of Organic Chemistry, p. 6138-6148, 2024
Tuning the Emission Properties of 2,1,3‐Benzothiadiazoles via Regioselective Substitution
Part of Chemistry - A European Journal, 2024
Access to long-lived room temperature phosphorescence through auration of 2,1,3-benzothiadiazole
Part of Dalton Transactions, p. 5658-5664, 2024
Photoinduced ring‐opening and phototoxicity of an indolin‐3‐one derivative
Part of Chemistry - A European Journal, 2023
An Indolin-3-imine Photobase and pH Sensitive Fluorophore
Part of ChemPhotoChem, 2023
Part of RSC Advances, p. 14544-14550, 2022
Part of ChemPhotoChem, p. 632-643, 2021
Prevalent Bioimaging Scaffolds: Synthesis, Photophysical Properties and Applications
Part of European Journal of Organic Chemistry, p. 2133-2144, 2021
Part of RSC Advances, p. 23960-23967, 2021
Mechanochemical synthesis of (hetero)aryl Au(i) complexes
Part of Green Chemistry, p. 5648-5655, 2020